Cancer immunotherapy: A comprehensive appraisal of its modes of application (Review)

Conventional cancer treatments such as chemotherapy and radiation therapy have reached their therapeutic potential, leaving a gap for developing more effective cancer therapeutics. Cancer cells evade the immune system using various mechanisms of immune tolerance, underlying the potential impact of i...

Full description

Saved in:
Bibliographic Details
Published in:Oncology letters 2021-09, Vol.22 (3), p.1, Article 655
Main Authors: Hoteit, Mira, Oneissi, Zeina, Reda, Ranim, Wakim, Fadi, Zaidan, Amar, Farran, Mohammad, Abi-Khalil, Elie, El-Sibai, Mirvat
Format: Article
Language:English
Subjects:
adoptive cell transfer
B cells
Cancer
Cancer Research
Cancer therapies
Cancer vaccines
Chemotherapy
Cytokines
Drug therapy
Health aspects
Human health sciences
immune checkpoint inhibitors
Immune response
Immune system
Immunotherapy
Kidney cancer
Lymphocytes
Melanoma
Metastasis
Monoclonal antibodies
Oncology
Polyethylene glycol
Proteins
Radiotherapy
Response rates
Review
Sciences de la santé humaine
Tumors
Vaccines
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c534t-bcc1c13dea465d1a3b232755f2dad2c2a203533beda70cb945773b4942f01f433
cites cdi_FETCH-LOGICAL-c534t-bcc1c13dea465d1a3b232755f2dad2c2a203533beda70cb945773b4942f01f433
container_end_page
container_issue 3
container_start_page 1
container_title Oncology letters
container_volume 22
creator Hoteit, Mira
Oneissi, Zeina
Reda, Ranim
Wakim, Fadi
Zaidan, Amar
Farran, Mohammad
Abi-Khalil, Elie
El-Sibai, Mirvat
description Conventional cancer treatments such as chemotherapy and radiation therapy have reached their therapeutic potential, leaving a gap for developing more effective cancer therapeutics. Cancer cells evade the immune system using various mechanisms of immune tolerance, underlying the potential impact of immunotherapy in the treatment of cancer. Immunotherapy includes several approaches such as activating the immune system in a cytokine-dependent manner, manipulating the feedback mechanisms involved in the immune response, enhancing the immune response via lymphocyte expansion and using cancer vaccines to elicit long-lasting, robust responses. These techniques can be used as monotherapies or combination therapies. The present review describes the immune-based mechanisms involved in tumor cell proliferation and maintenance and the rationale underlying various treatment methods. In addition, the present review provides insight into the potential of immunotherapy used alone or in combination with various types of therapeutics. Key words: cytokines, immune checkpoint inhibitors, adoptive cell transfer, vaccines, monoclonal antibodies
doi_str_mv 10.3892/ol.2021.12916
format article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8299024</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A677211806</galeid><sourcerecordid>A677211806</sourcerecordid><originalsourceid>FETCH-LOGICAL-c534t-bcc1c13dea465d1a3b232755f2dad2c2a203533beda70cb945773b4942f01f433</originalsourceid><addsrcrecordid>eNptUk1r3DAQNaElCWmOvRsKpT14K41sye6hsCz9gkAgpOdBlsdrBdlyJXtD_n29uyFkodJBI817T9LMS5L3nK1EWcEX71bAgK84VFyeJZdcVZBxVsKbl1jlF8l1jA9sGYXkZSnPkwuRi1IypS6T-40eDIXU9v08-KmjoMenr-k6Nb4fA3U0RLujVI9j0DZql_o2tVNMe99Q3G-WjLNGT9YP6ac72ll6_PwuedtqF-n6eb1K_vz4fr_5ld3c_vy9Wd9kphD5lNXGcMNFQzqXRcO1qEGAKooWGt2AAQ1MFELU1GjFTF3lhVKizqscWsbbXIir5NtRd5zrnhpDwxS0wzHYXocn9NriaWawHW79DkuoKgb5IiCOAs7SltCH2uIODsRDPLstaoM1IYAsUXApOVtYH56vDf7vTHHCBz-HYfkpQiEZCFHBK9RWO0I7tH55gultNLiWSgHnJZMLavUf1DIb6q3xA7V2OT8hfHxF6Ei7qYvezfsGxFNgdgSa4GMM1L7UhTPcuwe9w7178OAe8Q9ICLOy</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2560233920</pqid></control><display><type>article</type><title>Cancer immunotherapy: A comprehensive appraisal of its modes of application (Review)</title><source>PubMed Central (Open Access)</source><creator>Hoteit, Mira ; Oneissi, Zeina ; Reda, Ranim ; Wakim, Fadi ; Zaidan, Amar ; Farran, Mohammad ; Abi-Khalil, Elie ; El-Sibai, Mirvat</creator><creatorcontrib>Hoteit, Mira ; Oneissi, Zeina ; Reda, Ranim ; Wakim, Fadi ; Zaidan, Amar ; Farran, Mohammad ; Abi-Khalil, Elie ; El-Sibai, Mirvat</creatorcontrib><description>Conventional cancer treatments such as chemotherapy and radiation therapy have reached their therapeutic potential, leaving a gap for developing more effective cancer therapeutics. Cancer cells evade the immune system using various mechanisms of immune tolerance, underlying the potential impact of immunotherapy in the treatment of cancer. Immunotherapy includes several approaches such as activating the immune system in a cytokine-dependent manner, manipulating the feedback mechanisms involved in the immune response, enhancing the immune response via lymphocyte expansion and using cancer vaccines to elicit long-lasting, robust responses. These techniques can be used as monotherapies or combination therapies. The present review describes the immune-based mechanisms involved in tumor cell proliferation and maintenance and the rationale underlying various treatment methods. In addition, the present review provides insight into the potential of immunotherapy used alone or in combination with various types of therapeutics. Key words: cytokines, immune checkpoint inhibitors, adoptive cell transfer, vaccines, monoclonal antibodies</description><identifier>ISSN: 1792-1074</identifier><identifier>ISSN: 1792-1082</identifier><identifier>EISSN: 1792-1082</identifier><identifier>DOI: 10.3892/ol.2021.12916</identifier><identifier>PMID: 34386077</identifier><language>eng</language><publisher>Athens: Spandidos Publications</publisher><subject>adoptive cell transfer ; B cells ; Cancer ; Cancer Research ; Cancer therapies ; Cancer vaccines ; Chemotherapy ; Cytokines ; Drug therapy ; Health aspects ; Human health sciences ; immune checkpoint inhibitors ; Immune response ; Immune system ; Immunotherapy ; Kidney cancer ; Lymphocytes ; Melanoma ; Metastasis ; Monoclonal antibodies ; Oncology ; Polyethylene glycol ; Proteins ; Radiotherapy ; Response rates ; Review ; Sciences de la santé humaine ; Tumors ; Vaccines</subject><ispartof>Oncology letters, 2021-09, Vol.22 (3), p.1, Article 655</ispartof><rights>COPYRIGHT 2021 Spandidos Publications</rights><rights>Copyright Spandidos Publications UK Ltd. 2021</rights><rights>Copyright © 2021, Spandidos Publications 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c534t-bcc1c13dea465d1a3b232755f2dad2c2a203533beda70cb945773b4942f01f433</citedby><cites>FETCH-LOGICAL-c534t-bcc1c13dea465d1a3b232755f2dad2c2a203533beda70cb945773b4942f01f433</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299024/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299024/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids></links><search><creatorcontrib>Hoteit, Mira</creatorcontrib><creatorcontrib>Oneissi, Zeina</creatorcontrib><creatorcontrib>Reda, Ranim</creatorcontrib><creatorcontrib>Wakim, Fadi</creatorcontrib><creatorcontrib>Zaidan, Amar</creatorcontrib><creatorcontrib>Farran, Mohammad</creatorcontrib><creatorcontrib>Abi-Khalil, Elie</creatorcontrib><creatorcontrib>El-Sibai, Mirvat</creatorcontrib><title>Cancer immunotherapy: A comprehensive appraisal of its modes of application (Review)</title><title>Oncology letters</title><description>Conventional cancer treatments such as chemotherapy and radiation therapy have reached their therapeutic potential, leaving a gap for developing more effective cancer therapeutics. Cancer cells evade the immune system using various mechanisms of immune tolerance, underlying the potential impact of immunotherapy in the treatment of cancer. Immunotherapy includes several approaches such as activating the immune system in a cytokine-dependent manner, manipulating the feedback mechanisms involved in the immune response, enhancing the immune response via lymphocyte expansion and using cancer vaccines to elicit long-lasting, robust responses. These techniques can be used as monotherapies or combination therapies. The present review describes the immune-based mechanisms involved in tumor cell proliferation and maintenance and the rationale underlying various treatment methods. In addition, the present review provides insight into the potential of immunotherapy used alone or in combination with various types of therapeutics. Key words: cytokines, immune checkpoint inhibitors, adoptive cell transfer, vaccines, monoclonal antibodies</description><subject>adoptive cell transfer</subject><subject>B cells</subject><subject>Cancer</subject><subject>Cancer Research</subject><subject>Cancer therapies</subject><subject>Cancer vaccines</subject><subject>Chemotherapy</subject><subject>Cytokines</subject><subject>Drug therapy</subject><subject>Health aspects</subject><subject>Human health sciences</subject><subject>immune checkpoint inhibitors</subject><subject>Immune response</subject><subject>Immune system</subject><subject>Immunotherapy</subject><subject>Kidney cancer</subject><subject>Lymphocytes</subject><subject>Melanoma</subject><subject>Metastasis</subject><subject>Monoclonal antibodies</subject><subject>Oncology</subject><subject>Polyethylene glycol</subject><subject>Proteins</subject><subject>Radiotherapy</subject><subject>Response rates</subject><subject>Review</subject><subject>Sciences de la santé humaine</subject><subject>Tumors</subject><subject>Vaccines</subject><issn>1792-1074</issn><issn>1792-1082</issn><issn>1792-1082</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNptUk1r3DAQNaElCWmOvRsKpT14K41sye6hsCz9gkAgpOdBlsdrBdlyJXtD_n29uyFkodJBI817T9LMS5L3nK1EWcEX71bAgK84VFyeJZdcVZBxVsKbl1jlF8l1jA9sGYXkZSnPkwuRi1IypS6T-40eDIXU9v08-KmjoMenr-k6Nb4fA3U0RLujVI9j0DZql_o2tVNMe99Q3G-WjLNGT9YP6ac72ll6_PwuedtqF-n6eb1K_vz4fr_5ld3c_vy9Wd9kphD5lNXGcMNFQzqXRcO1qEGAKooWGt2AAQ1MFELU1GjFTF3lhVKizqscWsbbXIir5NtRd5zrnhpDwxS0wzHYXocn9NriaWawHW79DkuoKgb5IiCOAs7SltCH2uIODsRDPLstaoM1IYAsUXApOVtYH56vDf7vTHHCBz-HYfkpQiEZCFHBK9RWO0I7tH55gultNLiWSgHnJZMLavUf1DIb6q3xA7V2OT8hfHxF6Ei7qYvezfsGxFNgdgSa4GMM1L7UhTPcuwe9w7178OAe8Q9ICLOy</recordid><startdate>20210901</startdate><enddate>20210901</enddate><creator>Hoteit, Mira</creator><creator>Oneissi, Zeina</creator><creator>Reda, Ranim</creator><creator>Wakim, Fadi</creator><creator>Zaidan, Amar</creator><creator>Farran, Mohammad</creator><creator>Abi-Khalil, Elie</creator><creator>El-Sibai, Mirvat</creator><general>Spandidos Publications</general><general>Spandidos Publications UK Ltd</general><general>D.A. Spandidos</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q33</scope><scope>5PM</scope></search><sort><creationdate>20210901</creationdate><title>Cancer immunotherapy: A comprehensive appraisal of its modes of application (Review)</title><author>Hoteit, Mira ; Oneissi, Zeina ; Reda, Ranim ; Wakim, Fadi ; Zaidan, Amar ; Farran, Mohammad ; Abi-Khalil, Elie ; El-Sibai, Mirvat</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c534t-bcc1c13dea465d1a3b232755f2dad2c2a203533beda70cb945773b4942f01f433</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>adoptive cell transfer</topic><topic>B cells</topic><topic>Cancer</topic><topic>Cancer Research</topic><topic>Cancer therapies</topic><topic>Cancer vaccines</topic><topic>Chemotherapy</topic><topic>Cytokines</topic><topic>Drug therapy</topic><topic>Health aspects</topic><topic>Human health sciences</topic><topic>immune checkpoint inhibitors</topic><topic>Immune response</topic><topic>Immune system</topic><topic>Immunotherapy</topic><topic>Kidney cancer</topic><topic>Lymphocytes</topic><topic>Melanoma</topic><topic>Metastasis</topic><topic>Monoclonal antibodies</topic><topic>Oncology</topic><topic>Polyethylene glycol</topic><topic>Proteins</topic><topic>Radiotherapy</topic><topic>Response rates</topic><topic>Review</topic><topic>Sciences de la santé humaine</topic><topic>Tumors</topic><topic>Vaccines</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hoteit, Mira</creatorcontrib><creatorcontrib>Oneissi, Zeina</creatorcontrib><creatorcontrib>Reda, Ranim</creatorcontrib><creatorcontrib>Wakim, Fadi</creatorcontrib><creatorcontrib>Zaidan, Amar</creatorcontrib><creatorcontrib>Farran, Mohammad</creatorcontrib><creatorcontrib>Abi-Khalil, Elie</creatorcontrib><creatorcontrib>El-Sibai, Mirvat</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Université de Liège - Open Repository and Bibliography (ORBI)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Oncology letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hoteit, Mira</au><au>Oneissi, Zeina</au><au>Reda, Ranim</au><au>Wakim, Fadi</au><au>Zaidan, Amar</au><au>Farran, Mohammad</au><au>Abi-Khalil, Elie</au><au>El-Sibai, Mirvat</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cancer immunotherapy: A comprehensive appraisal of its modes of application (Review)</atitle><jtitle>Oncology letters</jtitle><date>2021-09-01</date><risdate>2021</risdate><volume>22</volume><issue>3</issue><spage>1</spage><pages>1-</pages><artnum>655</artnum><issn>1792-1074</issn><issn>1792-1082</issn><eissn>1792-1082</eissn><abstract>Conventional cancer treatments such as chemotherapy and radiation therapy have reached their therapeutic potential, leaving a gap for developing more effective cancer therapeutics. Cancer cells evade the immune system using various mechanisms of immune tolerance, underlying the potential impact of immunotherapy in the treatment of cancer. Immunotherapy includes several approaches such as activating the immune system in a cytokine-dependent manner, manipulating the feedback mechanisms involved in the immune response, enhancing the immune response via lymphocyte expansion and using cancer vaccines to elicit long-lasting, robust responses. These techniques can be used as monotherapies or combination therapies. The present review describes the immune-based mechanisms involved in tumor cell proliferation and maintenance and the rationale underlying various treatment methods. In addition, the present review provides insight into the potential of immunotherapy used alone or in combination with various types of therapeutics. Key words: cytokines, immune checkpoint inhibitors, adoptive cell transfer, vaccines, monoclonal antibodies</abstract><cop>Athens</cop><pub>Spandidos Publications</pub><pmid>34386077</pmid><doi>10.3892/ol.2021.12916</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1792-1074
ispartof Oncology letters, 2021-09, Vol.22 (3), p.1, Article 655
issn 1792-1074
1792-1082
1792-1082
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8299024
source PubMed Central (Open Access)
subjects adoptive cell transfer
B cells
Cancer
Cancer Research
Cancer therapies
Cancer vaccines
Chemotherapy
Cytokines
Drug therapy
Health aspects
Human health sciences
immune checkpoint inhibitors
Immune response
Immune system
Immunotherapy
Kidney cancer
Lymphocytes
Melanoma
Metastasis
Monoclonal antibodies
Oncology
Polyethylene glycol
Proteins
Radiotherapy
Response rates
Review
Sciences de la santé humaine
Tumors
Vaccines
title Cancer immunotherapy: A comprehensive appraisal of its modes of application (Review)
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T05%3A32%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cancer%20immunotherapy:%20A%20comprehensive%20appraisal%20of%20its%20modes%20of%20application%20(Review)&rft.jtitle=Oncology%20letters&rft.au=Hoteit,%20Mira&rft.date=2021-09-01&rft.volume=22&rft.issue=3&rft.spage=1&rft.pages=1-&rft.artnum=655&rft.issn=1792-1074&rft.eissn=1792-1082&rft_id=info:doi/10.3892/ol.2021.12916&rft_dat=%3Cgale_pubme%3EA677211806%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c534t-bcc1c13dea465d1a3b232755f2dad2c2a203533beda70cb945773b4942f01f433%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2560233920&rft_id=info:pmid/34386077&rft_galeid=A677211806&rfr_iscdi=true